The Zacks Analyst Blog Highlights:Hillshire Brands, Pilgrim's Pride, Summer Infant, NN and UnitedHealth Group
CHICAGO, June 3, 2014 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Hillshire Brands Co. (NYSE:HSH-Free Report), Pilgrim's Pride Corp. (Nasdaq:PPC-Free Report), Summer Infant, Inc. (Nasdaq:SUMR-Free Report), NN Inc. (Nasdaq:NNBR-Free Report) and UnitedHealth Group Inc. (NYSE:UNH-Free Report).
Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.
Here are highlights from Monday's Analyst Blog:
3 Best Performing Stocks from May
A series of positive economic reports over the month helped negate concerns from GDP and personal consumption data. Comments from the Federal Reserve and positive economic developments also gave benchmarks a boost. All the indices gained over the month, indicating that the second half of the year may be a good one for the markets.
May's Performance
The S&P 500, the Dow and the Nasdaq gained 2.1%, 0.8% and 3.1%, respectively. May's gains helped the Nasdaq and the blue-chip index turn positive for the year.
Gains in small-cap and high-growth stocks drove benchmarks higher for the month. Additionally, gains in consumer discretionary and energy stocks helped benchmarks finish in the green. The Nasdaq was boosted primarily by gains in bio-tech stocks. Merger deals including Hillshire Brands Co. (NYSE:HSH-Free Report) and Pilgrim's Pride Corp. (Nasdaq:PPC-Free Report) also added to optimism.
The Federal Open Market Committee's indication that the central bank will remain flexible when it comes to raising short term interest rates also boosted investor sentiment. Federal Reserve Chairwoman Janet Yellen indicated key lending rates would remain low. Russian President Vladimir Putin's willingness to discuss measures to ease the Ukrainian crisis and dovish comments from ECB President Mario Draghi were some of the other positives for the month.
Most economic indicators were on the positive side during May. This includes small-business sentiment, ISM Services Index and initial claims numbers. March's retail sales data was revised upward, adding to the optimism.
GDP Data and Other Economic Reports
First quarter GDP growth was lower than expected. According to the "second estimate" by the Bureau of Economic Analysis, the first quarter output of goods and services produced by labor and property located in the United States decreased at an annual rate of 1.0%, more than the consensus estimate of a decrease by 0.5%.
This decline in first quarter GDP was in sharp contrast to the "advance" estimate that predicted an increase of 0.1%. The US economy shrank in the first quarter for the first time in three years. Harsh winter weather was cited for hampering business operations and slowing down construction. In the fourth quarter, the US economy had expanded 2.6%.
However, investors have chosen to focus on the fact that most economic reports released last month were on the positive side. This includes data on consumer confidence, durable orders, and the housing sector. Last week's decline in initial claims was another significant boost for the markets. The number of people applying for unemployment benefits last week touched the second-lowest level since the end of recession in mid-2009.
3 Star Performers for May
I ran a screen on Research Wizard for companies with the following parameters:
(Click here to sign up for a free trial to the Research Wizard today):
- Percentage price change over the last 4 weeks greater than or equal to 20%
- Forward price-to-earnings Ratios (P/E) for the current financial year (F1) less than or equal to 25. This picks out stocks that are good value choices
- Expected earnings growth for the current financial year greater than or equal to 20%
- Zacks Rank less than or equal to 2: This ascertains stocks that have shown above-average returns over the last 26 years.
(See the performance of Zacks' portfolios and strategies here:About Zacks Performance).
Here are the top 3 stocks among the 5 that made it through this screen:
Summer Infant, Inc.
Summer Infant, Inc. (Nasdaq:SUMR-Free Report) designs, markets and distributes branded durable juvenile health, safety and wellness products which are sold principally to large U.S. retailers. The company currently sells proprietary products in a number of different categories. These products include nursery audio/video monitors, safety gates, durable bath products, bed rails, infant thermometers and related nursery, health and safety products.
Percentage price gain over the last 4 weeks = 53.76%
Summer Infant, Inc. holds a Zacks Rank #1 (Strong Buy). The stock's forward price-to-earnings Ratios (P/E) for the current financial year (F1) is 19.95.
Willdan Group, Inc.
Willdan Group, Inc. (WLDN) offers consulting and technical services to utilities, government agencies and industrial and commercial companies. The company provides services in four different segments. These are: Homeland Security, Energy Efficiency, Engineering and Public Finance. Willdan has several offices, primarily in New York and California.
Percentage price change over the last 4 weeks = 34.41%
Expected earnings growth for FY2014 = 82.86%
Currently, the company holds a Zacks Rank #1 (Strong Buy) and has a P/E (F1) of 9.77.
NN Inc.
NN Inc. (Nasdaq:NNBR-Free Report) is an independent manufacturer and supplier of high quality, precision steel balls and rollers to both domestic and international anti-friction bearing manufacturers. NN also manufacturers a full line of precision injection molded components serving the bearing, automotive, instrumentation, fiber optic and consumer hardware markets.
Percentage price change over the last 4 weeks = 27.69%
Expected earnings growth for FY2014 = 35.92%
Apart from a Zacks Rank #1 (Strong Buy),NN Inc. has a P/E (F1) of 17.52.
The Momentum for These Stocks Remain
Most reports released last month indicate that growth will soon pick up, reversing this month's decline. According to some estimates, GDP growth in the second quarter could be at 4% or even higher. However, consensus estimates indicate growth of at least 3% or more. The pace of growth is expected to accelerate over the second half of the year and this trend is expected to continue.
Benchmarks' progress into record territory reflects this inherent optimism of the U.S. economic outlook. Despite some residual weakness, technology stocks have also recovered and are expected to move upward. Going forward, the reasonably low price to earnings ratios and top Zacks Rank make these stocks good additions to your portfolios.
UnitedHealth Down to Sell
On May 31, 2014, Zacks Investment Research downgradedUnitedHealth Group Inc. (NYSE:UNH-Free Report) to a Zacks Rank #4 (Sell).
Why the Downgrade?
UnitedHealth Group has witnessed downward estimate revisions for 2014 and 2015 after lukewarm first-quarter earnings, which surpassed the Zacks Consensus by just a penny but declined a drastic 31% year over year. Total revenue of $31.7 billion also lagged the Zacks Consensus Estimate of $32.0 billion.
During the first quarter, negative impact from the Affordable Care Act (ACA) and sequestration cuts were nearly 35 cents per share. Operating margins also fell 90 basis points to 4.8%.
The insurer is looked upon cautiously by investors who foresee its profits being whittled by industry taxes from the ACA. They are also apprehensive about the new costly drug, Sovaldi, which could drain UnitedHealth's earnings in the ensuing quarters.
The Zacks Consensus Estimate for 2014 is down 1.25% to $5.52 per share over the last 60 days as 13 out of 17 estimates moved south. The same for 2015 fell 1.30% to $6.06 per share as 11 out of 16 estimates were lowered over the same time frame.
Going forward, the Medicare Reimbursement Cuts are also likely to drag the insurer's earnings.
UnitedHealth had experienced low level of medical care utilization over the last three years, leading to reduced medical claim cost and increased profits. However, management expects a return to a more normalized medical utilization trend soon that will wipe out the extra earnings benefit that the company was enjoying.
Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today.
About Zacks
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros.
Get the full Report on HSH - FREE
Get the full Report on PPC - FREE
Get the full Report on SUMR - FREE
Get the full Report on NNBR - FREE
Get the full Report on UNH - FREE
Follow us on Twitter: http://twitter.com/zacksresearch
Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Logo - http://photos.prnewswire.com/prnh/20101027/ZIRLOGO
SOURCE Zacks Investment Research, Inc.
Share this article